Not exact matches
In addition, there was no effect on breastfeeding duration when the pacifier was introduced at 1 month of age.280 A more recent systematic review found that the highest level of evidence (ie, from
clinical trials) does not support an adverse relationship between pacifier use and breastfeeding duration or exclusivity.281 The association between shortened duration of breastfeeding and pacifier use in observational
studies likely reflects a number of complex factors such as breastfeeding difficulties or intent to wean.281 A large multicenter, randomized controlled
trial of 1021 mothers who were highly motivated to breastfeed were
assigned to 2 groups: mothers advised to offer a pacifier after 15 days and mothers advised not to offer a pacifier.
Another problem is that modeling
studies, like this one, are inherently less powerful than other kinds of medical research: randomized
clinical trials, the gold standard in medical research, in which patients are randomly
assigned different treatments or no treatment; case - control
studies, which compare patients who have a condition with those who do not; or cohort
studies, which determine the risk of contracting a disease by
studying a group of people with similar demographics.
Often
clinical studies fall short of the rigorous methodology demanded by «gold standard»
clinical trials, in which patients are
assigned to treatment groups at random and nobody knows which group is which.
Hence, a total of 90 patients from nine centers were randomly
assigned to one of two
study arms for the phase II
clinical trial: the first taking capsules of olaparib (400 mg twice daily) and the other taking a combination of the two drugs (200 mg olaparib in capsule - form twice daily and 30 mg tablets of cediranib once daily).
In the
study, researchers combined data from 11
clinical trials in which patients were randomly
assigned to receive calcium supplements or placebo pills.